Coastlands Capital LP (CIK 2068530) reported 7 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-07-16). Recent activity: Buy ADIL (2,000 shares), Buy ADIL (1,233 shares), Buy ADIL (10,053 shares), Buy ADIL (1,700 shares), Buy ADIL (25,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-16 | ADIAL PHARMACEUTICALS, INC. (ADIL) | 10% Owner | Buy | 2,000 | $5,300 |
| 2026-07-16 | ADIAL PHARMACEUTICALS, INC. (ADIL) | 10% Owner | Buy | 1,233 | $3,391 |
| 2026-07-13 | ADIAL PHARMACEUTICALS, INC. (ADIL) | 10% Owner | Buy | 10,053 | $28,048 |
| 2026-07-13 | ADIAL PHARMACEUTICALS, INC. (ADIL) | 10% Owner | Buy | 1,700 | $4,590 |
| 2026-07-01 | ADIAL PHARMACEUTICALS, INC. (ADIL) | 10% Owner | Buy | 25,000 | $65,000 |
| 2026-06-22 | Pasithea Therapeutics Corp. (KTTA) | 10% Owner | Buy | 100,000 | $53,000 |
| 2026-05-29 | Eloxx Pharmaceuticals, Inc. (ELOX) | 10% Owner | Sell | 1.2M | $0 |
Source: SEC Form 4 filings · as of 2026-07-16